Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Exelixis, Inc. is an oncology company. The Company has produced four marketed pharmaceutical products, two of which are formulations of its flagship molecule, cabozantinib. It is also advancing and evolving its product pipeline portfolio, including its lead investigational asset, zanzalintinib. Cabozantinib is an inhibitor of multiple tyrosine kinases, including MET, AXL, VEGF receptors and RET and has been also approved as CABOMETYX tablets for advanced renal cell carcinoma, for previously treated hepatocellular carcinoma and for previously treated, radioactive iodine-refractory differentiated thyroid cancer, and as COMETRIQ capsules for progressive, metastatic medullary thyroid cancer. The Company's other two products are COTELLIC, an inhibitor of MEK approved as part of multiple combination regimens to treat specific forms of advanced melanoma and MINNEBRO an oral, non-steroidal, selective blocker of the mineralocorticoid receptor approved the treatment of hypertension in Japan.
Find out what a historical investment in Exelixis, Inc. would be worth today using our EXEL stock calculator.
Buying EXEL shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Exelixis, Inc. in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in EXEL
What is the ticker symbol of Exelixis, Inc.?
The ticker symbol for Exelixis, Inc. is EXEL.
How much is one share of EXEL?
One share of EXEL is valued at $64.63 as of 22 November 2026.
What is the market capitalisation of Exelixis, Inc. EXEL?
As of 22 November 2026 Exelixis, Inc. has a market cap of $15.77B.
What is the P/E ratio of EXEL?
The Price to Earnings ratio of EXEL is 19.75.
What is the Earnings Per Share of EXEL?
The Earnings Per Share of EXEL is $3.33.
What is the 52-week high for Exelixis, Inc. stock?
The Exelixis, Inc. 52-week high stock price is $73.69.
What is the 52-week low for Exelixis, Inc. stock?
The Exelixis, Inc. 52-week low stock price is $39.71.
Can I buy EXEL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy EXEL shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in EXEL on Stake
Buy EXEL from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of EXEL from only US$10 with fractional shares